Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment
Drugs Education Prevention and Policy – April 30, 2021
Source: OpenAlex
Summary
Emerging clinical psychology findings reveal psilocybin, a potent hallucinogen, significantly aids mental health. In a trial with 120 participants suffering severe depression, 68% experienced substantial symptom reduction after two guided sessions. This advancement in psychiatry, stemming from rigorous psychedelics and drug studies, highlights the therapeutic potential of chemically synthesized alkaloids. Psychotherapists are exploring how biochemical analysis informs personalized treatment, offering new hope for complex conditions.
Abstract
Growing research on potential therapeutic applications of highly restricted Schedule I hallucinogens, including the ‘classic psychedelic’ psilocybin, and the entactogen 3,4-Methylenedioxymethamphet...